TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
JBIO

Jade Biosciences, Inc.

Healthcare · Biotechnology

14.40$ -2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow JBIO
Line item 2020 2021 2022 2023 2024 2025
– – – – – –
– +1,400.0% +353.3% +41.2% +193.8% -90.8%
– – – – – +796,436.6%
– -768.4% – +26.3% -214.0% –
– – +7.7% -27.2% -100.0% –
– – – +71.5% +371.8% -540.9%
– – – – – –
– +2,035.6% -99.8% +11,515.2% -44.7% +1,318.8%
– +4,585.9% -164.1% – +837.8% +85.7%
– – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?